Indian stock markets opened in selling pressure on Thursday, following a global decline triggered by U.S. President Donald Trump's latest tariff announcement. Investors reacted negatively, leading to ...
Sun Pharma(Rs. 471.67 crore), Tejas Networks(Rs. 456.41 crore), IDFC First Bank(Rs. 440.42 crore), Dr. Reddys(Rs. 417.55 ...
India’s benchmark indices opened lower on Thursday following U.S. President Donald Trump's decision to impose a 26 per cent ...
The Indian market is expected to open lower on Thursday as global cues remain weak following U.S. President Trump’s ...
Equity indices decline due to US reciprocal tariffs, impacting Indian markets; Sensex and Nifty fall in early trade.
Sensex and Nifty plummet as US imposes new tariffs, impacting Indian markets. IT stocks drive the decline amid weak Asian ...
Pharma stocks surge after US exempts products from tariffs, Nifty Pharma and healthcare indices show positive gains.
Sensex and Nifty slipped in early trade on Thursday, tracking weak global cues after US President Donald Trump imposed 26 per ...
Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from ...
AM, all 20 Nifty Pharma constituents traded in the green. Among others, Gland Pharma was up 7.74 per cent, Lupin was up over ...
The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results